Olga Millan

Barcelona, CT 08036, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Dried Blood Spot for CXCL-10 and Tacrolimus: Integrated Non-Invasive Monitoring to Guide Personalized Treatment in Adult Kidney Transplant Recipients.

Dried Blood Spot for CXCL-10 and Tacrolimus: Integrated Non-Invasive Monitoring to Guide Personalized Treatment in Adult Kidney Transplant Recipients.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: December 22, 2025

Plasma microRNAs and chemokines as biomarkers for rejection in liver transplantation with score verification and tissue correlation.

Plasma microRNAs and chemokines as biomarkers for rejection in liver transplantation with score verification and tissue correlation.

Journal: Scientific reports

Published: September 02, 2025

Tacrolimus-Associated Tremor in Renal Transplant Patients: Potential Impact of the Galenic Formulation.

Tacrolimus-Associated Tremor in Renal Transplant Patients: Potential Impact of the Galenic Formulation.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: August 12, 2025

Donor-derived cell-free DNA and miRNA monitoring for the early prediction and diagnosis of liver allograft rejection and patient outcomes.

Donor-derived cell-free DNA and miRNA monitoring for the early prediction and diagnosis of liver allograft rejection and patient outcomes.

Journal: Frontiers in immunology

Published: April 01, 2025

miRNAs, dd-cf-DNA, and Chemokines as Potential Noninvasive Biomarkers for the Assessment of Clinical Graft Evolution and Personalized Immunosuppression Requirement in Solid Organ Transplantation.

miRNAs, dd-cf-DNA, and Chemokines as Potential Noninvasive Biomarkers for the Assessment of Clinical Graft Evolution and Personalized Immunosuppression Requirement in Solid Organ Transplantation.

Journal: Therapeutic drug monitoring

Published: August 01, 2024

Everolimus Personalized Therapy: Second Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.

Everolimus Personalized Therapy: Second Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.

Journal: Therapeutic drug monitoring

Published: February 08, 2024

A plasmatic score using a miRNA signature and CXCL-10 for accurate prediction and diagnosis of liver allograft rejection.

A plasmatic score using a miRNA signature and CXCL-10 for accurate prediction and diagnosis of liver allograft rejection.

Journal: Frontiers in immunology

Published: March 30, 2023

Getting immunosuppression just right: the role of clinical biomarkers in predicting patient response post solid organ transplantation.

Getting immunosuppression just right: the role of clinical biomarkers in predicting patient response post solid organ transplantation.

Journal: Expert review of clinical pharmacology

Published: October 05, 2021

Advantages of plasmatic CXCL-10 as a prognostic and diagnostic biomarker for the risk of rejection and subclinical rejection in kidney transplantation.

Advantages of plasmatic CXCL-10 as a prognostic and diagnostic biomarker for the risk of rejection and subclinical rejection in kidney transplantation.

Journal: Clinical immunology (Orlando, Fla.)

Published: January 27, 2021

Monitoring of gene expression in tacrolimus-treated de novo renal allograft recipients facilitates individualized immunosuppression: Results of the IMAGEN study.

Monitoring of gene expression in tacrolimus-treated de novo renal allograft recipients facilitates individualized immunosuppression: Results of the IMAGEN study.

Journal: British journal of clinical pharmacology

Published: November 10, 2020

Personalized Therapy for Mycophenolate: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.

Personalized Therapy for Mycophenolate: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.

Journal: Therapeutic drug monitoring

Published: November 03, 2020

Early prognostic performance of miR155-5p monitoring for the risk of rejection: Logistic regression with a population pharmacokinetic approach in adult kidney transplant patients.

Early prognostic performance of miR155-5p monitoring for the risk of rejection: Logistic regression with a population pharmacokinetic approach in adult kidney transplant patients.

Journal: PloS one

Published: August 21, 2020

Showing 1-12 of 35

Last Updated: 09/26/2026